[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Jupiter Neurosciences Inc (JUNS)

Jupiter Neurosciences Inc (JUNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Jupiter Neurosciences Inc 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 USA

https://jupiterneurosciences.com Employees: 10 P: 561-406-6154

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Jupiter Neurosciences Inc. is a clinical-stage pharmaceutical company focused on treating neuroinflammation, with a current focus on CNS disorders and rare diseases. The Company's pipeline is focused broadly on CNS disorder and includes indications such as Alzheimer's Disease, Parkinson's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia and MELAS. Jupiter Neurosciences Inc. is based in Jupiter, Florida.

Key Statistics

Overview:

Market Capitalization, $K 4,390
Enterprise Value, $K 600
Shares Outstanding, K 36,281
Float, K 22,277
% Float 61.40%
Short Interest, K 939
Short Float 2.59%
Days to Cover 1.00
Short Volume Ratio 0.34
% of Insider Shareholders 38.60%

Financials:

Annual Sales, $ 20 K
Annual Net Income, $ -8,640 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -2,060 K
EBIT, $ -9,350 K
EBITDA, $ -9,310 K

Growth:

1-Year Return -92.75%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 05/14/26
Next Earnings Date 08/17/26 [--]
Earnings Per Share ttm -0.27
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year -20.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

JUNS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -228.64%
Profit Margin % -43,200.00%
Debt/Equity 0.00
Price/Sales 252.32
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.08
Interest Coverage -122.43
60-Month Beta 1.73
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.